TITLE

Scarce vaccine supplies in an influenza pandemic should not be distributed randomly: reply to McLachlan

AUTHOR(S)
Wardrope, Alistair
PUB. DATE
December 2012
SOURCE
Journal of Medical Ethics;Dec2012, Vol. 38 Issue 12, p765
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In a recent paper, Hugh McLachlan argues from a deontological perspective that the most ethical means of distributing scarce supplies of an effective vaccine in the context of an influenza pandemic would be via an equal lottery. I argue that, even if one accepts McLachlan's ethical theory, it does not follow that one should accept the vaccine lottery. McLachlan's argument relies upon two suppressed premises which, I maintain, one need not accept; and it misconstrues vaccination programmes as clinical interventions targeted solely at protecting the health of vaccinated individuals, rather than as public health interventions targeted at protecting the health of the population as a whole.
ACCESSION #
84022958

 

Related Articles

  • Pandemic Influenza Vaccine: The US Government Is Not Doing Enough. Osterholm, M. T. // Clinical Pharmacology & Therapeutics;Dec2007, Vol. 82 Issue 6, p635 

    The article reflects on pandemic influenza vaccine and the approaches taken by the U.S. government. It mentions that the current situation of H5N1 avian influenza virus infections in humans and animals in Asia and Europe gives a glimpse of pandemics in future. It opines that neither governments...

  • Mutant menace.  // Down to Earth;3/16/2015, Vol. 23 Issue 21, p31 

    The article focuses on the unpredictable nature of influenza viruses, making them difficult to prevent and manage. Topics discussed include the deterioration of the efficacy of seasonal influenza vaccines to protect the public from avian or swine influenza viruses, the need to raise awareness on...

  • Understandings of influenza and influenza vaccination among high-risk urban dwelling Thai adults: a qualitative study. Payaprom, Y.; Bennett, P.; Burnard, P.; Alabaster, E.; Tantipong, H. // Journal of Public Health;Mar2010, Vol. 32 Issue 1, p26 

    Background: The 2004 outbreak of influenza A H5N1 and the WHO's recommendation for national pandemic plans has led the Thai Ministry of Public Health to develop an influenza vaccination programme for high-risk adults. To date there is no available information to guide this intervention, and how...

  • Facemasks, Hand Hygiene, and Influenza among Young Adults: A Randomized Intervention Trial. Aiello, Allison E.; Perez, Vanessa; Coulborn, Rebecca M.; Davis, Brian M.; Uddin, Monica; Monto, Arnold S. // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Limited vaccine availability and the potential for resistance to antiviral medications have led to calls for establishing the efficacy of non-pharmaceutical measures formitigating pandemic influenza. Our objectivewas to examine if the use of facemasks and hand hygiene reduced rates of...

  • A Serine12Stop mutation in PB1-F2 of the 2009 pandemic (H1N1) influenza A: a possible reason for its enhanced transmission and pathogenicity to humans. Ramakrishnan, Muthannan A.; Gramer, Marie R.; Goyal, Sagar M.; Sreevatsan, Srinand // Journal of Veterinary Science;2009, Vol. 10 Issue 4, p349 

    As the scientific community scrambles to define the ancestry and lineages of the eight segments of new pandemic H1N1 strain, we looked for unique genetic events in this virus's genome to explain the newly found enhanced virulence and transmissibility among humans. Genome annotations of this...

  • Pandemic Influenza - Prevention and Treatment. Snell, Noel J. C. // Pharmaceutical Medicine - New Zealand;2010, Vol. 24 Issue 1, p1 

    The author discusses pandemic influenza with particular focus on prevention and treatment. The characteristics of the three influenza viruses A, B and C, and the origin of influenza, its symptoms and complications are tackled. The recommended measures to prevent contracting the disease include...

  • Vaccine news from the 7th World Congress of the IHEA.  // PharmacoEconomics & Outcomes News;7/25/2009, Issue 583, p5 

    The article discusses studies which evaluated the cost-effectiveness of influenza vaccines, presented at the 7th World Congress of the International Health Economics Association (IHEA). One study investigated the cost effectiveness of a universal influenza immunisation programme (UIIP) in...

  • Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. Chor, Josette S. Y.; Ngai, Karry L. K.; Goggins, William B.; Wong, Martin C. S.; Wong, Samuel Y. S.; Lee, Nelson; Ting-fan Leung; Rainer, Timothy H.; Griffiths, Sian; Chan, Paul K. S. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/12/2009, Vol. 339 Issue 7721, p618 

    The article discusses a study which investigated the proportion of hospital based healthcare workers in Hong Kong that accept pre-pandemic influenza vaccination. The questionnaires in the surveys conducted at 31 hospital departments from January to March 2009 were completed by 2255 healthcare...

  • Rapid production of a HN influenza vaccine from MDCK cells for protecting chicken against influenza virus infection. Ren, Zhenghua; Lu, Zhongzheng; Wang, Lei; Huo, Zeren; Cui, Jianhua; Zheng, Tingting; Dai, Qing; Chen, Cuiling; Qin, Mengying; Chen, Meihua; Yang, Rirong // Applied Microbiology & Biotechnology;Apr2015, Vol. 99 Issue 7, p2999 

    HN subtype avian influenza viruses are widespread in domestic poultry, and vaccination remains the most effective way to protect the chicken population from avian influenza pandemics. Currently, egg-based HN influenza vaccine production has several disadvantages and mammalian MDCK cells are...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics